COMMUNIQUÉS West-GlobeNewswire

Medical patients’ access to Hydropothecary cannabis products remains a priority for HEXO Corp
30/10/2018
GATINEAU, Quebec, Oct. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp has wasted no time in reassuring its current medical patients that it has safeguarded products and bandwidth to continue to deliver the quality, award- [...]
Accès des patients aux produits de cannabis Hydropothecary : toujours une priorité pour HEXO Corp
30/10/2018
GATINEAU, Québec,, 30 oct. 2018 (GLOBE NEWSWIRE) -- HEXO Corp s’empresse de rassurer les patients qui font actuellement partie de sa clientèle médicale : suffisamment de stocks de toute sa gamme ont été mis de côté pour [...]
ProQR obtient de Ionis Pharmaceuticals des droits mondiaux sous licence sur un médicament candidat en ophtalmologie
30/10/2018
ProQR reçoit une licence mondiale exclusive pour IONIS-RHO-2.5 Rx , désormais dénommé QR-1123, destiné au traitement de la rétinite pigmentaire autosomique dominante (adRP), une forme rare de cécité héréditaire sans [...]
Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia Therapeutics
30/10/2018
Keryx Board Unanimously Supports Merger with Akebia and Encourages Stockholders to vote “ FOR ” the Merger Proposals Keryx Special Meeting of Stockholders Scheduled for December 11, 2018 BOSTON, Oct. 30, 2018 (GLOBE [...]
UPDATE - Cutera to Present at Three Upcoming Healthcare Conferences
30/10/2018
BRISBANE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Helix BioPharma Corp. Closes Private Placement
30/10/2018
RICHMOND HILL, Ontario, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Golden Leaf Holdings Acquires Cultivation License for Bald Peak Facility in Oregon
30/10/2018
PORTLAND, Ore., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2018 Earnings and Corporate Developments
30/10/2018
CAMBRIDGE, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]
Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada
30/10/2018
COLUMBIA, Md., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow
30/10/2018
TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
CooperSurgical, Inc. Launches PGTai Technology Platform and ERPeak Endometrial Receptivity Test
30/10/2018
TRUMBULL, Conn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CooperSurgical, Inc. announced the launch of the CooperGenomics SM PGTai SM technology platform and ERPeak SM endometrial receptivity test at ASRM 2018. The PGTai SM [...]
CymaBay to Report Third Quarter 2018 Financial Results on Tuesday, November 6
30/10/2018
NEWARK, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Prothena to Report Third Quarter 2018 Financial Results on November 6
30/10/2018
DUBLIN, Ireland, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the third quarter and first nine months of 2018 on [...]
Cutera to Present at Three Upcoming Healthcare Conferences
30/10/2018
BRISBANE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
BioTelemetry, Inc. Reports Third Quarter 2018 Financial Results
30/10/2018
Company’s Results Exceed Expectations Company Raises Full-Year Guidance MALVERN, Pa., Oct. 30, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company [...]
KemPharm Enters Into License Agreement with KVK Tech for the Commercialization of APADAZ®
30/10/2018
Partnership with KVK, One of the Largest Manufacturers of Controlled Substances in the U.S., Opens the Door for Commercial Launch of APADAZ with PBMs and MCOs KemPharm to Host a Conference Call Today, Tuesday, October [...]
electroCore, Inc. to Report Third Quarter Financial Results on November 13, 2018
30/10/2018
BASKING RIDGE, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]
Myriad Genetics to Present at the Stephens New York Investment Conference
30/10/2018
SALT LAKE CITY, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that R. Bryan Riggsbee, CFO, is scheduled to present [...]
CytomX Therapeutics to Announce Third Quarter 2018 Financial Results
30/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Pages